Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill Belch

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
VASA. Zeitschrift Fur Gefasskrankheiten|July 5, 2019
The compelling arguments for the need of medical vascular physicians in EuropeChristian Heiss, Juraj Madaric, Jill Belch, et al.
Arthritis Research & Therapy|February 5, 2015
An important role for A20-binding inhibitor of nuclear factor-kB-1 (ABIN1) in inflammation-mediated endothelial dysfunction: an in vivo study in ABIN1 (D485N) miceNaveed Akbar, Sambit Nanda, Jill Belch, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|September 6, 2022
Vascular risk assessment and managementPaola Bigolin, Beniamino Zalunardo, Lucia Mazzolai, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|September 5, 2022
Supervised exercise training in patients with lower extremity peripheral artery diseaseStefano Lanzi, Jill Belch, Marianne Brodmann, et al.
International Journal of Epidemiology|June 23, 2015
Prime mover or fellow traveller: 25-hydroxy vitamin D's seasonal variation, cardiovascular disease and death in the Scottish Heart Health Extended Cohort (SHHEC)Hugh Tunstall-Pedoe, Mark Woodward, Maria Hughes, et al.
Lancet (London, England)|May 31, 2011
Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemiaJill Belch, William R Hiatt, Iris Baumgartner, et al.
Journal of Vascular Nursing : Official Publication of the Society for Peripheral Vascular Nursing|March 12, 2026
Exploring patients' experiences of using Transcutaneous Electrical Nerve Stimulation for ClaudicationChris Seenan, Stephanie Hill, Ukachukwu Abaraogu, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|April 23, 2024
Adverse reactions after intravascular iodinated contrast media administration and their managementMária Rašiová, Oliver Schlager, Christian Heiss, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|November 20, 2018
Urgent need to clarify the definition of chronic critical limb ischemia - a position paper from the European Society for Vascular MedicineJoël Constans, Alessandra Bura-Rivière, Adriana Visona, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 8, 2022
Antithrombotic therapy following revascularization for chronic limb-threatening ischaemia: a European survey from the ESC Working Group on Aorta and Peripheral Vascular DiseasesMarco De Carlo, Oliver Schlager, Lucia Mazzolai, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
VASA. Zeitschrift Fur Gefasskrankheiten|July 5, 2019
The compelling arguments for the need of medical vascular physicians in EuropeChristian Heiss, Juraj Madaric, Jill Belch, et al.
Arthritis Research & Therapy|February 5, 2015
An important role for A20-binding inhibitor of nuclear factor-kB-1 (ABIN1) in inflammation-mediated endothelial dysfunction: an in vivo study in ABIN1 (D485N) miceNaveed Akbar, Sambit Nanda, Jill Belch, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|September 6, 2022
Vascular risk assessment and managementPaola Bigolin, Beniamino Zalunardo, Lucia Mazzolai, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|September 5, 2022
Supervised exercise training in patients with lower extremity peripheral artery diseaseStefano Lanzi, Jill Belch, Marianne Brodmann, et al.
International Journal of Epidemiology|June 23, 2015
Prime mover or fellow traveller: 25-hydroxy vitamin D's seasonal variation, cardiovascular disease and death in the Scottish Heart Health Extended Cohort (SHHEC)Hugh Tunstall-Pedoe, Mark Woodward, Maria Hughes, et al.
Lancet (London, England)|May 31, 2011
Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemiaJill Belch, William R Hiatt, Iris Baumgartner, et al.
Journal of Vascular Nursing : Official Publication of the Society for Peripheral Vascular Nursing|March 12, 2026
Exploring patients' experiences of using Transcutaneous Electrical Nerve Stimulation for ClaudicationChris Seenan, Stephanie Hill, Ukachukwu Abaraogu, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|April 23, 2024
Adverse reactions after intravascular iodinated contrast media administration and their managementMária Rašiová, Oliver Schlager, Christian Heiss, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|November 20, 2018
Urgent need to clarify the definition of chronic critical limb ischemia - a position paper from the European Society for Vascular MedicineJoël Constans, Alessandra Bura-Rivière, Adriana Visona, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 8, 2022
Antithrombotic therapy following revascularization for chronic limb-threatening ischaemia: a European survey from the ESC Working Group on Aorta and Peripheral Vascular DiseasesMarco De Carlo, Oliver Schlager, Lucia Mazzolai, et al.
Pageof 3